<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34663622</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>04</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-330X</ISSN><JournalIssue CitedMedium="Internet"><Volume>93</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of neurology, neurosurgery, and psychiatry</Title><ISOAbbreviation>J Neurol Neurosurg Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Sensitivity of brain MRI and neurological examination for detection of upper motor neurone degeneration in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>82</StartPage><EndPage>92</EndPage><MedlinePgn>82-92</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/jnnp-2021-327269</ELocationID><Abstract><AbstractText Label="OBJECTIVES">To investigate sensitivity of brain MRI and neurological examination for detection of upper motor neuron (UMN) degeneration in patients with amyotrophic lateral sclerosis (ALS).</AbstractText><AbstractText Label="METHODS">We studied 192 patients with ALS and 314 controls longitudinally. All patients visited our centre twice and underwent full neurological examination and brain MRI. At each visit, we assessed UMN degeneration by measuring motor cortex thickness (CT) and pyramidal tract fibre density (FD) corresponding to five body regions (bulbar region and limbs). For each body region, we measured degree of clinical UMN and lower motor neuron (LMN) symptom burden using a validated scoring system.</AbstractText><AbstractText Label="RESULTS">We found deterioration over time of CT of motor regions (p&#x2264;0.0081) and progression of UMN signs of bulbar region and left arm (p&#x2264;0.04). FD was discriminative between controls and patients with moderate/severe UMN signs (all regions, p&#x2264;0.034), but did not change longitudinally. Higher clinical UMN burden correlated with reduced CT, but not lower FD, for the bulbar region (p=2.2&#xd7;10<sup>-10</sup>) and legs (p&#x2264;0.025). In the arms, we found that severe LMN signs may reduce the detectability of UMN signs (p&#x2264;0.043). With MRI, UMN degeneration was detectable before UMN signs became clinically evident (CT: p=1.1&#xd7;10<sup>-10</sup>, FD: p=6.3&#xd7;10<sup>-4</sup>). Motor CT, but not FD, deteriorated more than UMN signs during the study period.</AbstractText><AbstractText Label="CONCLUSIONS">Motor CT is a more sensitive measure of UMN degeneration than UMN signs. Motor CT and pyramidal tract FD are discriminative between patients and controls. Brain MRI can monitor UMN degeneration before signs become clinically evident. These findings promote MRI as a potential biomarker for UMN progression in clinical trials in ALS.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nitert</LastName><ForeName>Abram D</ForeName><Initials>AD</Initials><Identifier Source="ORCID">0000-0001-7941-6663</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University Medical Centre Utrecht Brain Centre, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Harold Hg</ForeName><Initials>HH</Initials><Identifier Source="ORCID">0000-0002-2981-9680</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University Medical Centre Utrecht Brain Centre, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walhout</LastName><ForeName>Ren&#xe9;e</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Medical Centre Utrecht Brain Centre, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knijnenburg</LastName><ForeName>Nienke L</ForeName><Initials>NL</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Medical Centre Utrecht Brain Centre, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Es</LastName><ForeName>Michael A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Medical Centre Utrecht Brain Centre, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Veldink</LastName><ForeName>Jan H</ForeName><Initials>JH</Initials><Identifier Source="ORCID">0000-0001-5572-9657</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University Medical Centre Utrecht Brain Centre, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hendrikse</LastName><ForeName>Jeroen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Radiology, University Medical Center Utrecht, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Westeneng</LastName><ForeName>Henk-Jan</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Medical Centre Utrecht Brain Centre, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>van den Berg</LastName><ForeName>Leonard H</ForeName><Initials>LH</Initials><Identifier Source="ORCID">0000-0002-6559-3965</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University Medical Centre Utrecht Brain Centre, Utrecht, The Netherlands L.H.vandenBerg@umcutrecht.nl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Neurol Neurosurg Psychiatry</MedlineTA><NlmUniqueID>2985191R</NlmUniqueID><ISSNLinking>0022-3050</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>doi: 10.1136/jnnp-2021-327948</RefSource></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="Y">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009044" MajorTopicYN="N">Motor Cortex</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N" Type="Geographic">Netherlands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059906" MajorTopicYN="N">Neuroimaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009460" MajorTopicYN="N">Neurologic Examination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011712" MajorTopicYN="N">Pyramidal Tracts</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">MRI</Keyword><Keyword MajorTopicYN="N">clinical neurology</Keyword></KeywordList><CoiStatement>Competing interests: LHvdB received travel grants and consultancy fees from Shire and serves on scientific advisory boards for Treeway, Cytokinetics, and Biogen, outside the submitted work. MAvE serves on the medical ethical review board of the UMC Utrecht and received travel grants from Shire and has consulted for Biogen, outside the submitted work. JHV reports having sponsored research agreements with Biogen, outside the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>5</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>19</Day><Hour>5</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34663622</ArticleId><ArticleId IdType="pmc">PMC8685620</ArticleId><ArticleId IdType="doi">10.1136/jnnp-2021-327269</ArticleId><ArticleId IdType="pii">jnnp-2021-327269</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kiernan MC, Vucic S, Cheah BC, et al. . Amyotrophic lateral sclerosis. Lancet 2011;377:942&#x2013;55. 10.1016/S0140-6736(10)61156-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Swash M. Why are upper motor neuron signs difficult to elicit in amyotrophic lateral sclerosis? J Neurol Neurosurg Psychiatry 2012;83:659&#x2013;62. 10.1136/jnnp-2012-302315</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-302315</ArticleId><ArticleId IdType="pubmed">22496581</ArticleId></ArticleIdList></Reference><Reference><Citation>Swash M, Burke D, Turner MR, et al. . Occasional essay: upper motor neuron syndrome in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2020;91:227&#x2013;34. 10.1136/jnnp-2019-321938</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2019-321938</ArticleId><ArticleId IdType="pubmed">32054724</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, Stambler N. Performance of the amyotrophic lateral sclerosis functional rating scale (ALSFRS) in multicenter clinical trials. J Neurol Sci 1997;152 Suppl 1:s1&#x2013;9. 10.1016/S0022-510X(97)00237-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(97)00237-2</ArticleId><ArticleId IdType="pubmed">9419047</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Sanjak M, Ringel S. The amyotrophic lateral sclerosis functional rating scale. assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (acts) phase I-II study Group. Arch Neurol 1996;53:141&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">8639063</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Hardiman O. Lessons of ALS imaging: Pitfalls and future directions - A critical review. Neuroimage Clin 2014;4:436&#x2013;43. 10.1016/j.nicl.2014.02.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2014.02.011</ArticleId><ArticleId IdType="pmc">PMC3950559</ArticleId><ArticleId IdType="pubmed">24624329</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon NG, Turner MR, Vucic S, et al. . Quantifying disease progression in amyotrophic lateral sclerosis. Ann Neurol 2014;76:643&#x2013;57. 10.1002/ana.24273</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24273</ArticleId><ArticleId IdType="pmc">PMC4305209</ArticleId><ArticleId IdType="pubmed">25223628</ArticleId></ArticleIdList></Reference><Reference><Citation>Huynh W, Simon NG, Grosskreutz J, et al. . Assessment of the upper motor neuron in amyotrophic lateral sclerosis. Clin Neurophysiol 2016;127:2643&#x2013;60. 10.1016/j.clinph.2016.04.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2016.04.025</ArticleId><ArticleId IdType="pubmed">27291884</ArticleId></ArticleIdList></Reference><Reference><Citation>Basaia S, Agosta F, Cividini C, et al. . Structural and functional brain connectome in motor neuron diseases: a multicenter MRI study. Neurology 2020;95:e2552&#x2013;64. 10.1212/WNL.0000000000010731</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010731</ArticleId><ArticleId IdType="pmc">PMC7682834</ArticleId><ArticleId IdType="pubmed">32913015</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Bokde A, Elamin M, et al. . Grey matter correlates of clinical variables in amyotrophic lateral sclerosis (ALS): a neuroimaging study of ALS motor phenotype heterogeneity and cortical focality. J Neurol Neurosurg Psychiatry 2013;84:766&#x2013;73. 10.1136/jnnp-2012-302674</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-302674</ArticleId><ArticleId IdType="pubmed">23085933</ArticleId></ArticleIdList></Reference><Reference><Citation>Machts J, Cardenas-Blanco A, Acosta-Cabronero J, et al. . Prefrontal cortical thickness in motor neuron disease. Neuroimage Clin 2018;18:648&#x2013;55. 10.1016/j.nicl.2018.03.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2018.03.002</ArticleId><ArticleId IdType="pmc">PMC5987868</ArticleId><ArticleId IdType="pubmed">29876256</ArticleId></ArticleIdList></Reference><Reference><Citation>Raffelt DA, Smith RE, Ridgway GR, et al. . Connectivity-based fixel enhancement: whole-brain statistical analysis of diffusion MRI measures in the presence of crossing fibres. Neuroimage 2015;117:40&#x2013;55. 10.1016/j.neuroimage.2015.05.039</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2015.05.039</ArticleId><ArticleId IdType="pmc">PMC4528070</ArticleId><ArticleId IdType="pubmed">26004503</ArticleId></ArticleIdList></Reference><Reference><Citation>St&#xe4;mpfli P, Sommer S, Czell D, et al. . Investigation of neurodegenerative processes in amyotrophic lateral sclerosis using white matter fiber density. Clin Neuroradiol 2019;29:493&#x2013;503. 10.1007/s00062-018-0670-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00062-018-0670-8</ArticleId><ArticleId IdType="pubmed">29460142</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S, Ziemann U, Eisen A, et al. . Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights. J Neurol Neurosurg Psychiatry 2013;84:1161&#x2013;70. 10.1136/jnnp-2012-304019</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-304019</ArticleId><ArticleId IdType="pmc">PMC3786661</ArticleId><ArticleId IdType="pubmed">23264687</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S, Lin CS-Y, Cheah BC, et al. . Riluzole exerts central and peripheral modulating effects in amyotrophic lateral sclerosis. Brain 2013;136:1361&#x2013;70. 10.1093/brain/awt085</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awt085</ArticleId><ArticleId IdType="pubmed">23616585</ArticleId></ArticleIdList></Reference><Reference><Citation>Walhout R, Westeneng H-J, Verstraete E, et al. . Cortical thickness in ALS: towards a marker for upper motor neuron involvement. J Neurol Neurosurg Psychiatry 2015;86:288&#x2013;94. 10.1136/jnnp-2013-306839</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2013-306839</ArticleId><ArticleId IdType="pubmed">25121571</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster C, Kasper E, Machts J, et al. . Focal thinning of the motor cortex mirrors clinical features of amyotrophic lateral sclerosis and their phenotypes: a neuroimaging study. J Neurol 2013;260:2856&#x2013;64. 10.1007/s00415-013-7083-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-013-7083-z</ArticleId><ArticleId IdType="pubmed">23996101</ArticleId></ArticleIdList></Reference><Reference><Citation>Sach M, Winkler G, Glauche V, et al. . Diffusion tensor MRI of early upper motor neuron involvement in amyotrophic lateral sclerosis. Brain 2004;127:340&#x2013;50. 10.1093/brain/awh041</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh041</ArticleId><ArticleId IdType="pubmed">14607785</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalra S, M&#xfc;ller H-P, Ishaque A, et al. . A prospective harmonized multicenter DTI study of cerebral white matter degeneration in ALS. Neurology 2020;95:e943&#x2013;52. 10.1212/WNL.0000000000010235</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010235</ArticleId><ArticleId IdType="pmc">PMC7668555</ArticleId><ArticleId IdType="pubmed">32646955</ArticleId></ArticleIdList></Reference><Reference><Citation>Huisman MHB, de Jong SW, van Doormaal PTC, et al. . Population based epidemiology of amyotrophic lateral sclerosis using capture-recapture methodology. J Neurol Neurosurg Psychiatry 2011;82:1165&#x2013;70. 10.1136/jnnp.2011.244939</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2011.244939</ArticleId><ArticleId IdType="pubmed">21622937</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, et al. . El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293&#x2013;9. 10.1080/146608200300079536</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Rascovsky K, Hodges JR, Kipps CM, et al. . Diagnostic criteria for the behavioral variant of frontotemporal dementia (bvFTD): current limitations and future directions. Alzheimer Dis Assoc Disord 2007;21:S14&#x2013;18. 10.1097/WAD.0b013e31815c3445</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WAD.0b013e31815c3445</ArticleId><ArticleId IdType="pubmed">18090417</ArticleId></ArticleIdList></Reference><Reference><Citation>Roche JC, Rojas-Garcia R, Scott KM, et al. . A proposed staging system for amyotrophic lateral sclerosis. Brain 2012;135:847&#x2013;52. 10.1093/brain/awr351</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr351</ArticleId><ArticleId IdType="pmc">PMC3286327</ArticleId><ArticleId IdType="pubmed">22271664</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Hammond ER, Mora G, et al. . Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2015;86:38&#x2013;44. 10.1136/jnnp-2013-306589</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2013-306589</ArticleId><ArticleId IdType="pubmed">24336810</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrahams S, Newton J, Niven E, et al. . Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener 2014;15:9&#x2013;14. 10.3109/21678421.2013.805784</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.805784</ArticleId><ArticleId IdType="pubmed">23781974</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravits J, Paul P, Jorg C. Focality of upper and lower motor neuron degeneration at the clinical onset of ALS. Neurology 2007;68:1571&#x2013;5. 10.1212/01.wnl.0000260965.20021.47</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000260965.20021.47</ArticleId><ArticleId IdType="pubmed">17485643</ArticleId></ArticleIdList></Reference><Reference><Citation>Devine MS, Kiernan MC, Heggie S, et al. . Study of motor asymmetry in ALS indicates an effect of limb dominance on onset and spread of weakness, and an important role for upper motor neurons. Amyotroph Lateral Scler Frontotemporal Degener 2014;15:481&#x2013;7. 10.3109/21678421.2014.906617</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.906617</ArticleId><ArticleId IdType="pubmed">24809721</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaller M, Hughes T. Inter-rater agreement of observable and elicitable neurological signs. Clin Med 2014;14:264&#x2013;7. 10.7861/clinmedicine.14-3-264</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmedicine.14-3-264</ArticleId><ArticleId IdType="pmc">PMC4952538</ArticleId><ArticleId IdType="pubmed">24889570</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischl B, Salat DH, Busa E, et al. . Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002;33:341&#x2013;55. 10.1016/s0896-6273(02)00569-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0896-6273(02)00569-x</ArticleId><ArticleId IdType="pubmed">11832223</ArticleId></ArticleIdList></Reference><Reference><Citation>Desikan RS, S&#xe9;gonne F, Fischl B, et al. . An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 2006;31:968&#x2013;80. 10.1016/j.neuroimage.2006.01.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2006.01.021</ArticleId><ArticleId IdType="pubmed">16530430</ArticleId></ArticleIdList></Reference><Reference><Citation>Penfield W, Boldrey E, Wilder Penfield EB. Somatic motor and sensory representation in the cerebral cortex of man as studied by electrical stimulation. Brain 1937;60:389&#x2013;443. 10.1093/brain/60.4.389</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/60.4.389</ArticleId></ArticleIdList></Reference><Reference><Citation>Tournier J-D, Calamante F, Connelly A. Robust determination of the fibre orientation distribution in diffusion MRI: non-negativity constrained super-resolved spherical deconvolution. Neuroimage 2007;35:1459&#x2013;72. 10.1016/j.neuroimage.2007.02.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2007.02.016</ArticleId><ArticleId IdType="pubmed">17379540</ArticleId></ArticleIdList></Reference><Reference><Citation>Chenot Q, Tzourio-Mazoyer N, Rheault F, et al. . A population-based atlas of the human pyramidal tract in 410 healthy participants. Brain Struct Funct 2019;224:599&#x2013;612. 10.1007/s00429-018-1798-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00429-018-1798-7</ArticleId><ArticleId IdType="pubmed">30460551</ArticleId></ArticleIdList></Reference><Reference><Citation>Meier JD, Aflalo TN, Kastner S, et al. . Complex organization of human primary motor cortex: a high-resolution fMRI study. J Neurophysiol 2008;100:1800&#x2013;12. 10.1152/jn.90531.2008</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.90531.2008</ArticleId><ArticleId IdType="pmc">PMC2576195</ArticleId><ArticleId IdType="pubmed">18684903</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsumoto H, Brooks BR, Silani V. Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved? Lancet Neurol 2014;13:1127&#x2013;38. 10.1016/S1474-4422(14)70129-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70129-2</ArticleId><ArticleId IdType="pubmed">25316019</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinelli EG, Riva N, Rancoita PMV, et al. . Structural MRI outcomes and predictors of disease progression in amyotrophic lateral sclerosis. Neuroimage Clin 2020;27:102315. 10.1016/j.nicl.2020.102315</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2020.102315</ArticleId><ArticleId IdType="pmc">PMC7327879</ArticleId><ArticleId IdType="pubmed">32593977</ArticleId></ArticleIdList></Reference><Reference><Citation>Menke RAL, K&#xf6;rner S, Filippini N, et al. . Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis. Brain 2014;137:2546&#x2013;55. 10.1093/brain/awu162</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu162</ArticleId><ArticleId IdType="pmc">PMC4132644</ArticleId><ArticleId IdType="pubmed">24951638</ArticleId></ArticleIdList></Reference><Reference><Citation>Westeneng H-J, Debray TPA, Visser AE, et al. . Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. Lancet Neurol 2018;17:423&#x2013;33. 10.1016/S1474-4422(18)30089-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30089-9</ArticleId><ArticleId IdType="pubmed">29598923</ArticleId></ArticleIdList></Reference><Reference><Citation>Verstraete E, Turner MR, Grosskreutz J, et al. . Mind the gap: the mismatch between clinical and imaging metrics in ALS. Amyotroph Lateral Scler Frontotemporal Degener 2015;16:524&#x2013;9. 10.3109/21678421.2015.1051989</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1051989</ArticleId><ArticleId IdType="pubmed">26402254</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippi M, Agosta F, Grosskreutz J, et al. . Progress towards a neuroimaging biomarker for amyotrophic lateral sclerosis. Lancet Neurol 2015;14:786&#x2013;8. 10.1016/S1474-4422(15)00134-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(15)00134-9</ArticleId><ArticleId IdType="pubmed">26194923</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakore NJ, Pioro EP. Laughter, crying and sadness in ALS. J Neurol Neurosurg Psychiatry 2017;88:825&#x2013;31. 10.1136/jnnp-2017-315622</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-315622</ArticleId><ArticleId IdType="pmc">PMC5629932</ArticleId><ArticleId IdType="pubmed">28572273</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravits JM, La Spada AR. ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration. Neurology 2009;73:805&#x2013;11. 10.1212/WNL.0b013e3181b6bbbd</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181b6bbbd</ArticleId><ArticleId IdType="pmc">PMC2739608</ArticleId><ArticleId IdType="pubmed">19738176</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Hardiman O. Longitudinal structural changes in ALS: a three time-point imaging study of white and gray matter degeneration. Amyotroph Lateral Scler Frontotemporal Degener 2018;19:232&#x2013;41. 10.1080/21678421.2017.1407795</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1407795</ArticleId><ArticleId IdType="pubmed">29214883</ArticleId></ArticleIdList></Reference><Reference><Citation>van Eijk RPA, Westeneng H-J, Nikolakopoulos S, et al. . Refining eligibility criteria for amyotrophic lateral sclerosis clinical trials. Neurology 2019;92:e451&#x2013;60. 10.1212/WNL.0000000000006855</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000006855</ArticleId><ArticleId IdType="pmc">PMC6369899</ArticleId><ArticleId IdType="pubmed">30626653</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller H-P, Agosta F, Riva N, et al. . Fast progressive lower motor neuron disease is an ALS variant: a two-centre tract of interest-based MRI data analysis. Neuroimage Clin 2018;17:145&#x2013;52. 10.1016/j.nicl.2017.10.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2017.10.008</ArticleId><ArticleId IdType="pmc">PMC5651542</ArticleId><ArticleId IdType="pubmed">29071208</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajagopalan V, Pioro EP. Differential involvement of corticospinal tract (CST) fibers in UMN-predominant ALS patients with or without CST hyperintensity: a diffusion tensor tractography study. Neuroimage Clin 2017;14:574&#x2013;9. 10.1016/j.nicl.2017.02.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2017.02.017</ArticleId><ArticleId IdType="pmc">PMC5349615</ArticleId><ArticleId IdType="pubmed">28337412</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajagopalan V, Allexandre D, Yue GH, et al. . Diffusion tensor imaging evaluation of corticospinal tract hyperintensity in upper motor Neuron-Predominant ALS patients. J Aging Res 2011;2011:481745 10.4061/2011/481745</Citation><ArticleIdList><ArticleId IdType="doi">10.4061/2011/481745</ArticleId><ArticleId IdType="pmc">PMC3205652</ArticleId><ArticleId IdType="pubmed">22132329</ArticleId></ArticleIdList></Reference><Reference><Citation>Verde F, Steinacker P, Weishaupt JH, et al. . Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2019;90:157&#x2013;64. 10.1136/jnnp-2018-318704</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-318704</ArticleId><ArticleId IdType="pubmed">30309882</ArticleId></ArticleIdList></Reference><Reference><Citation>Zucchi E, Bedin R, Fasano A, et al. . Cerebrospinal fluid neurofilaments may discriminate upper motor neuron syndromes: a pilot study. Neurodegener Dis 2018;18:255&#x2013;61. 10.1159/000493986</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000493986</ArticleId><ArticleId IdType="pubmed">30428468</ArticleId></ArticleIdList></Reference><Reference><Citation>Matamala JM, Howells J, Dharmadasa T, et al. . Inter-session reliability of short-interval intracortical inhibition measured by threshold tracking TMS. Neurosci Lett 2018;674:18&#x2013;23. 10.1016/j.neulet.2018.02.065</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2018.02.065</ArticleId><ArticleId IdType="pubmed">29501687</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo JH, Wang S, Melhem ER, et al. . Linear associations between clinically assessed upper motor neuron disease and diffusion tensor imaging metrics in amyotrophic lateral sclerosis. PLoS One 2014;9:e105753. 10.1371/journal.pone.0105753</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0105753</ArticleId><ArticleId IdType="pmc">PMC4140827</ArticleId><ArticleId IdType="pubmed">25144708</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>